0 references
Delayed Booster Dosing Improves Human Antigen-Specific IG and B Cell Responses to the RH5.1/AS01 <sub>B</sub> Malaria Vaccine
SSRN Electronic Journal2022
Carolyn M. Nielsen, Jordan R. Barrett, Christine L. Davis, Jon Fallon, Cyndi Goh, Ashlin R. Michell, Catherine L. Griffin, Andrew Kwok, Carolin Loos, Samuel Darko, Farida Laboune, Sarah E. Silk, Mehmet Tekman, Joe Francica, Amy Ransier, Ruth Payne, Angela M. Minassian, Douglas A. Lauffenburger, Robert A. Seder, Daniel C. Douek, Galit Alter, Simon J. Draper
Related Papers
- → Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel(2021)1,227 cited
- → Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine(2022)15 cited
- → Effectiveness and duration of a second COVID-19 vaccine booster(2022)2 cited
- STUDY ON IMMUNORESPONSIBILITY TO BOOSTER INJECTION OF HBV VACCINATION(1993)
- → Protection following BNT162b2 booster substantially exceeds that of a fresh 2-dose vaccine: a quasi-experimental study(2021)